Baillie Gifford & Co’s 1Life Healthcare ONEM Stock Holding History

Baillie Gifford & Co’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-537	Closed	-$8.97K	–	487
2022 Q4	$8.97K	Hold	537	–	–	﹤0.01%	419
2022 Q3	$9K	Buy	537 +92	+21%	+$1.44K	﹤0.01%	419
2022 Q2	$3K	Hold	445	–	–	﹤0.01%	469
2022 Q1	$5K	Hold	445	–	–	﹤0.01%	471
2021 Q4	$8K	Hold	445	–	–	﹤0.01%	463
2021 Q3	$9K	Hold	445	–	–	﹤0.01%	461
2021 Q2	$15K	Hold	445	–	–	﹤0.01%	391
2021 Q1	$17K	Buy	445 +13	+3%	+$610	﹤0.01%	356
2020 Q4	$19K	Buy	+432	New	+$14.8K	﹤0.01%	328

Baillie Gifford & Co's ONEM Position: Q1 2023 in Review

Baillie Gifford & Co sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 537 shares — an estimated $8.97K sold.

Baillie Gifford & Co first reported a position in ONEM in Q4 2020 and held it in 9 quarters. The position peaked at $19K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Baillie Gifford & Co reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Baillie Gifford & Co sold 537 1Life Healthcare shares in Q1 2023, an estimated $8.97K.
Baillie Gifford & Co first reported a position in 1Life Healthcare in Q4 2020 and held it in 9 quarters.
Baillie Gifford & Co's 1Life Healthcare position peaked at $19K in Q4 2020.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.